Champions Oncology(CSBR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CSBR Champions Oncology

Pre-Mkt 02-20 08:27:20 EST

6.05

+0.24

+4.13%

High6.17	Low5.87	Vol4.02K
Open5.87	D1 Closing5.81	Amplitude5.16%
Mkt Cap84.01M	Tradable Cap31.39M	Total Shares13.89M
T/O24.22K	T/O Rate0.08%	Tradable Shares5.19M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CSBR","market":"US","secType":"STK","nameCN":"Champions Oncology","latestPrice":6.05,"timestamp":1771534800000,"preClose":5.81,"halted":0,"volume":4022,"delay":0,"changeRate":0.04130808950086062,"floatShares":5189122,"shares":13886326,"eps":0.174506,"marketStatus":"Pre-Mkt","change":0.24,"latestTime":"02-20 08:27:20 EST","open":5.87,"high":6.17,"low":5.87,"amount":24223.6557,"amplitude":0.051635,"askPrice":7.9,"askSize":100,"bidPrice":5.27,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.174506,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771597800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":6.05,"postHourTrading":{"tag":"盘后","latestPrice":6.05,"preClose":6.05,"latestTime":"16:04 EST","volume":1,"amount":6.05,"timestamp":1771535046651,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5110676346984001,"impliedVol":3.1689,"impliedVolPercentile":0.928},"requestUrl":"/m/hq/s/CSBR","defaultTab":"news","newsList":[{"id":"2604491197","title":"Champions Oncology Inc. Files Initial Statement of Beneficial Ownership for Director Robert Lawrence Brainin","url":"https://stock-news.laohu8.com/highlight/detail?id=2604491197","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604491197?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:49","pubTimestamp":1768600174,"startTime":"0","endTime":"0","summary":"Champions Oncology Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names Robert Lawrence Brainin as the beneficial owner, who serves as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL3v6pNB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Champions Oncology Inc. Files Initial Statement of Beneficial Ownership for Director Robert Lawrence Brainin","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BK4121"],"gpt_icon":0},{"id":"2591624878","title":"Cancer research firm Champions Oncology's Q2 revenue rises as bookings quality improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2591624878","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591624878?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:12","pubTimestamp":1765833126,"startTime":"0","endTime":"0","summary":"Cancer research firm Champions Oncology's Q2 revenue rises as bookings quality improvesOverviewTranslational oncology research firm's fiscal Q2 revenue rose 11% yr/yr to $15 mlnCompany reported net in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nL1N3XL0X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BK4121"],"gpt_icon":0},{"id":"2591562125","title":"Champions Oncology Q2 Adj. EPS $0.06 Beats $0.01 Estimate, Sales $15.035M Beat $14.042M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2591562125","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591562125?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:01","pubTimestamp":1765832494,"startTime":"0","endTime":"0","summary":"Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.01 by 500 percent. This is a 20 percent increase over earnings of $0.05 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/12/49406108/champions-oncology-q2-adj-eps-0-06-beats-0-01-estimate-sales-15-035m-beat-14-042m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Champions Oncology Q2 Adj. EPS $0.06 Beats $0.01 Estimate, Sales $15.035M Beat $14.042M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2591621233","title":"BRIEF-Champions Oncology Q2 Adjusted EPS USD 0.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2591621233","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591621233?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:00","pubTimestamp":1765832446,"startTime":"0","endTime":"0","summary":"BRIEF-Champions Oncology Q2 Adjusted EPS USD 0.06\n\n\nDec 15 (Reuters) - Champions Oncology Q2 EPS USD 0.02.\n\nQ2 revenue USD 15 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nPLXFCE50C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR","BK4121"],"gpt_icon":0},{"id":"2591662123","title":"Champions Oncology Q2 service revenue rises 11% to USD 15 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2591662123","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591662123?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:00","pubTimestamp":1765832432,"startTime":"0","endTime":"0","summary":"Champions Oncology Inc. reported its financial results for the second quarter  and first half  of fiscal 2026. For Q2, total revenue was USD 15 million, representing an 11 percent increase. Oncology services profit reached USD 7.8 million, with an oncology services margin of 52 percent. Net income for the quarter was USD 0.2 million. Adjusted EBITDA for Q2 was USD 0.8 million. For the first half of fiscal 2026, total revenue was USD 29 million, a 5 percent increase. Oncology services profit was USD 13.8 million, with a margin of 47 percent. Adjusted EBITDA for the period was USD 1.0 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via ACCESS ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDLbBCsMl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"gpt_icon":0},{"id":"2577591166","title":"Craig-Hallum Sticks to Their Buy Rating for Champions Oncology (CSBR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2577591166","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577591166?lang=en_us&edition=fundamental","pubTime":"2025-10-24 17:36","pubTimestamp":1761298569,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Matt Hewitt from Craig-Hallum maintained a Buy rating on Champions Oncology. The company’s shares closed yesterday ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-champions-oncology-csbr-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-sticks-to-their-buy-rating-for-champions-oncology-csbr-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"gpt_icon":0},{"id":"2576552779","title":"Champions Oncology Holds Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2576552779","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576552779?lang=en_us&edition=fundamental","pubTime":"2025-10-17 05:28","pubTimestamp":1760650105,"startTime":"0","endTime":"0","summary":"Champions Oncology ( ($CSBR) ) has issued an update. On October 16, 2025, Champions Oncology, Inc. held its Annual Meeting of Stockholders, where k...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/champions-oncology-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/champions-oncology-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CSBR"],"gpt_icon":0},{"id":"2568445193","title":"Champions Oncology Earnings Call: Cautious Optimism Amid Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2568445193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568445193?lang=en_us&edition=fundamental","pubTime":"2025-09-18 08:03","pubTimestamp":1758153791,"startTime":"0","endTime":"0","summary":"Champions Oncology (($CSBR)) has held its Q1 earnings call. Read on for the main highlights of the call. The recent earnings call for Champions Onc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/champions-oncology-earnings-call-cautious-optimism-amid-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/champions-oncology-earnings-call-cautious-optimism-amid-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"gpt_icon":0},{"id":"2567191100","title":"Craig-Hallum Remains a Buy on Champions Oncology (CSBR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567191100","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567191100?lang=en_us&edition=fundamental","pubTime":"2025-09-16 20:55","pubTimestamp":1758027346,"startTime":"0","endTime":"0","summary":"In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Champions Oncology, with a price target of $12.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-remains-a-buy-on-champions-oncology-csbr-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-remains-a-buy-on-champions-oncology-csbr-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR","BK4121"],"gpt_icon":0},{"id":"2567548910","title":"The Market Lifts Champions Oncology, Inc. (NASDAQ:CSBR) Shares 27% But It Can Do More","url":"https://stock-news.laohu8.com/highlight/detail?id=2567548910","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567548910?lang=en_us&edition=fundamental","pubTime":"2025-09-16 18:39","pubTimestamp":1758019172,"startTime":"0","endTime":"0","summary":"Champions Oncology, Inc. ( NASDAQ:CSBR ) shareholders would be excited to see that the share price has had a great...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-csbr/champions-oncology/news/the-market-lifts-champions-oncology-inc-nasdaqcsbr-shares-27","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-csbr/champions-oncology/news/the-market-lifts-champions-oncology-inc-nasdaqcsbr-shares-27","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NVIW.SI","SQQQ","USAW.SI","NQmain","CSBR","BK4121","PSQ","USJW.SI","TQQQ",".IXIC","TSYW.SI","MNQmain","QLD","QID"],"gpt_icon":1},{"id":"2567178230","title":"Champions Oncology Reports Steady Revenue and New Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=2567178230","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567178230?lang=en_us&edition=fundamental","pubTime":"2025-09-16 11:52","pubTimestamp":1757994740,"startTime":"0","endTime":"0","summary":"Champions Oncology ( ($CSBR) ) has released its Q1 earnings. Here is a breakdown of the information Champions Oncology presented to its investors. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/champions-oncology-reports-steady-revenue-and-new-leadership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/champions-oncology-reports-steady-revenue-and-new-leadership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"gpt_icon":0},{"id":"2567814223","title":"Champions Oncology Q1 Adjusted EPS USD 0.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2567814223","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567814223?lang=en_us&edition=fundamental","pubTime":"2025-09-16 04:08","pubTimestamp":1757966912,"startTime":"0","endTime":"0","summary":"Sep 15 (Reuters) - Champions Oncology Q1 EPS USD -0.03.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 15-SEP-202519:55:46.663 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nRSD5L8lgq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2567426471","title":"Champions Oncology Reports $14 Million Revenue for Q1 FY 2026, Adjusted EBITDA at $60,000; Revenue Slightly Lower Than Last Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2567426471","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567426471?lang=en_us&edition=fundamental","pubTime":"2025-09-16 03:55","pubTimestamp":1757966121,"startTime":"0","endTime":"0","summary":"Champions Oncology Reports $14 Million Revenue for Q1 FY 2026, Adjusted EBITDA at $60,000; Revenue Slightly Lower Than Last Year. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via ACCESS Newswire  on September 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDLcgMh9k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2567019249","title":"Champions Oncology Inc  expected to post a loss of 1 cent a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2567019249","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567019249?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:08","pubTimestamp":1757707685,"startTime":"0","endTime":"0","summary":"Champions Oncology Inc  expected to post a loss of 1cent a share - Earnings Preview Champions Oncology Inc CSBR.OQ CSBR.O is expected to  show a fall in quarterly revenue when it reports  results on S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nL5N3UZ1EF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2566641971","title":"Craig-Hallum Reaffirms Their Buy Rating on Champions Oncology (CSBR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2566641971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566641971?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:36","pubTimestamp":1757680565,"startTime":"0","endTime":"0","summary":"Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Champions Oncology today. The company’s shares closed yesterday at $6.46. Hewitt covers...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/craig-hallum-reaffirms-their-buy-rating-on-champions-oncology-csbr-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/craig-hallum-reaffirms-their-buy-rating-on-champions-oncology-csbr-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CSBR"],"gpt_icon":0},{"id":"2565957552","title":"Champions Oncology Inc  expected to post a loss of 1 cent a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2565957552","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565957552?lang=en_us&edition=fundamental","pubTime":"2025-09-05 19:01","pubTimestamp":1757070116,"startTime":"0","endTime":"0","summary":"Champions Oncology Inc  expected to post a loss of 1cent a share - Earnings Preview Champions Oncology Inc CSBR.OQ CSBR.O is expected to  show a fall in quarterly revenue when it reports  results on S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250905:nL8N3US0JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2561407896","title":"Champions Oncology Inc. Announces Date for Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2561407896","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561407896?lang=en_us&edition=fundamental","pubTime":"2025-08-23 03:21","pubTimestamp":1755890488,"startTime":"0","endTime":"0","summary":"Champions Oncology, Inc. has scheduled its Annual Meeting of Stockholders to be held on October 16, 2025. The meeting will take place at the company's headquarters in Hackensack, New Jersey. Stockholders will gather to discuss and vote on various company matters, as specified in the notice of the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL5lblW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CSBR"],"gpt_icon":0},{"id":"2553724085","title":"Champions Oncology Q4 Adj. EPS $(0.07) Beats $(0.20) Estimate, Sales $12.355M Beat $12.013M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2553724085","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553724085?lang=en_us&edition=fundamental","pubTime":"2025-07-24 04:01","pubTimestamp":1753300869,"startTime":"0","endTime":"0","summary":"Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.20) by 65 percent. This is a 800 percent decrease over earnings of $0.01 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/07/46586179/champions-oncology-q4-adj-eps-0-07-beats-0-20-estimate-sales-12-355m-beat-12-013m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2553385240","title":"Champions Oncology Reports Record $57M Annual Revenue, Net Income of $4.6M, and 14% Growth in Fiscal 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553385240","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553385240?lang=en_us&edition=fundamental","pubTime":"2025-07-24 04:00","pubTimestamp":1753300824,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Champions Oncology Inc. published the original content used to generate this news brief via ACCESS Newswire  on July 23, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL9JR5vv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSBR"],"gpt_icon":0},{"id":"2553247771","title":"Champions Oncology Q4 Adjusted Ebitda USD -1.016 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2553247771","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553247771?lang=en_us&edition=fundamental","pubTime":"2025-07-24 04:00","pubTimestamp":1753300801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nPLXD7EC56:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSBR","BK4121"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.championsoncology.com","stockEarnings":[{"period":"1week","weight":0.0168},{"period":"1month","weight":-0.1357},{"period":"3month","weight":-0.1064},{"period":"6month","weight":-0.2071},{"period":"1year","weight":-0.4398},{"period":"ytd","weight":-0.1245}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.1167},{"period":"ytd","weight":0.0038}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.","yearOnYearQuotes":[{"month":1,"riseRate":0.421053,"avgChangeRate":0.083367},{"month":2,"riseRate":0.578947,"avgChangeRate":0.006261},{"month":3,"riseRate":0.368421,"avgChangeRate":0.017872},{"month":4,"riseRate":0.368421,"avgChangeRate":-0.021152},{"month":5,"riseRate":0.473684,"avgChangeRate":0.052943},{"month":6,"riseRate":0.473684,"avgChangeRate":0.049271},{"month":7,"riseRate":0.368421,"avgChangeRate":-0.033896},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.010162},{"month":9,"riseRate":0.578947,"avgChangeRate":0.093837},{"month":10,"riseRate":0.315789,"avgChangeRate":0.015826},{"month":11,"riseRate":0.368421,"avgChangeRate":-0.003679},{"month":12,"riseRate":0.578947,"avgChangeRate":0.128252}],"exchange":"NASDAQ","name":"Champions Oncology","nameEN":"Champions Oncology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Champions Oncology(CSBR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Champions Oncology(CSBR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Champions Oncology,CSBR,Champions Oncology股票,Champions Oncology股票老虎,Champions Oncology股票老虎国际,Champions Oncology行情,Champions Oncology股票行情,Champions Oncology股价,Champions Oncology股市,Champions Oncology股票价格,Champions Oncology股票交易,Champions Oncology股票购买,Champions Oncology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Champions Oncology(CSBR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Champions Oncology(CSBR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction